De Stefano, N <br/><br/>
The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing-remitting multiple sclerosis.  [electronic resource] 

 -  Multiple sclerosis (Houndmills, Basingstoke, England)  Feb 2009 
 - 238-43 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1352-4585 
<br/><br/><label>Standard No.: </label>10.1177/1352458508098269  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Chemistry, Pharmaceutical<br/>Dose-Response Relationship, Drug<br/>Female<br/>Glatiramer Acetate<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Injections, Subcutaneous<br/>Male<br/>Molecular Weight<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy<br/>Peptides--administration & dosage<br/>Pilot Projects<br/>Treatment Outcome